224 related articles for article (PubMed ID: 21402050)
21. Inhibition of fibronectin binding and fibronectin-mediated cell adhesion to collagen by a peptide from the second type I repeat of thrombospondin.
Sipes JM; Guo N; Nègre E; Vogel T; Krutzsch HC; Roberts DD
J Cell Biol; 1993 Apr; 121(2):469-77. PubMed ID: 8468356
[TBL] [Abstract][Full Text] [Related]
22. Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity.
Maity G; Choudhury PR; Sen T; Ganguly KK; Sil H; Chatterjee A
Tumour Biol; 2011 Feb; 32(1):129-38. PubMed ID: 20821288
[TBL] [Abstract][Full Text] [Related]
23. Shear stress induced release of von Willebrand factor and thrombospondin-1 in HUVEC extracellular matrix enhances breast tumour cell adhesion.
Gomes N; Legrand C; Fauvel-Lafève F
Clin Exp Metastasis; 2005; 22(3):215-23. PubMed ID: 16158249
[TBL] [Abstract][Full Text] [Related]
24. Calcium indirectly regulates immunochemical reactivity and functional activities of the N-domain of thrombospondin-1.
Calzada MJ; Kuznetsova SA; Sipes JM; Rodrigues RG; Cashel JA; Annis DS; Mosher DF; Roberts DD
Matrix Biol; 2008 May; 27(4):339-51. PubMed ID: 18226512
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of αvβ3 integrin impairs adhesion and uptake of tumor-derived small extracellular vesicles.
Altei WF; Pachane BC; Dos Santos PK; Ribeiro LNM; Sung BH; Weaver AM; Selistre-de-Araújo HS
Cell Commun Signal; 2020 Sep; 18(1):158. PubMed ID: 32988382
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer.
Fukui T; Kondo M; Ito G; Maeda O; Sato N; Yoshioka H; Yokoi K; Ueda Y; Shimokata K; Sekido Y
Oncogene; 2005 Sep; 24(41):6323-7. PubMed ID: 16007200
[TBL] [Abstract][Full Text] [Related]
27. Zinc inhibits magnesium-dependent migration of human breast cancer MDA-MB-231 cells on fibronectin.
Lymburner S; McLeod S; Purtzki M; Roskelley C; Xu Z
J Nutr Biochem; 2013 Jun; 24(6):1034-40. PubMed ID: 23026493
[TBL] [Abstract][Full Text] [Related]
28. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.
Pannone G; Bufo P; Santoro A; Franco R; Aquino G; Longo F; Botti G; Serpico R; Cafarelli B; Abbruzzese A; Caraglia M; Papagerakis S; Lo Muzio L
Oncol Rep; 2010 Oct; 24(4):1035-41. PubMed ID: 20811686
[TBL] [Abstract][Full Text] [Related]
29. Chelidonine suppresses migration and invasion of MDA-MB-231 cells by inhibiting formation of the integrin-linked kinase/PINCH/α-parvin complex.
Kim O; Hwangbo C; Kim J; Li DH; Min BS; Lee JH
Mol Med Rep; 2015 Aug; 12(2):2161-8. PubMed ID: 25890994
[TBL] [Abstract][Full Text] [Related]
30. Progranulin stimulated by LPA promotes the migration of aggressive breast cancer cells.
Swamydas M; Nguyen D; Allen LD; Eddy J; Dréau D
Cell Commun Adhes; 2011 Dec; 18(6):119-30. PubMed ID: 22176685
[TBL] [Abstract][Full Text] [Related]
31. The Netrin-related domain of Sfrp1 interacts with Wnt ligands and antagonizes their activity in the anterior neural plate.
Lopez-Rios J; Esteve P; Ruiz JM; Bovolenta P
Neural Dev; 2008 Aug; 3():19. PubMed ID: 18715500
[TBL] [Abstract][Full Text] [Related]
32. Canonical Wnt pathway gene expression and their clinical correlation in oral squamous cell carcinoma.
Marimuthu M; Andiappan M; Wahab A; Muthusekhar MR; Balakrishnan A; Shanmugam S
Indian J Dent Res; 2018; 29(3):291-297. PubMed ID: 29900911
[TBL] [Abstract][Full Text] [Related]
33. Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1.
Nunes SS; Outeiro-Bernstein MA; Juliano L; Vardiero F; Nader HB; Woods A; Legrand C; Morandi V
J Cell Physiol; 2008 Mar; 214(3):828-37. PubMed ID: 17879962
[TBL] [Abstract][Full Text] [Related]
34. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
35. SFRPs Are Biphasic Modulators of Wnt-Signaling-Elicited Cancer Stem Cell Properties beyond Extracellular Control.
Liang CJ; Wang ZW; Chang YW; Lee KC; Lin WH; Lee JL
Cell Rep; 2019 Aug; 28(6):1511-1525.e5. PubMed ID: 31390565
[TBL] [Abstract][Full Text] [Related]
36. The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma.
Kongkham PN; Northcott PA; Croul SE; Smith CA; Taylor MD; Rutka JT
Oncogene; 2010 May; 29(20):3017-24. PubMed ID: 20208569
[TBL] [Abstract][Full Text] [Related]
37. Differences in integrin expression and signaling within human breast cancer cells.
Taherian A; Li X; Liu Y; Haas TA
BMC Cancer; 2011 Jul; 11():293. PubMed ID: 21752268
[TBL] [Abstract][Full Text] [Related]
38. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
39. A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breast epithelial cells.
Säfholm A; Leandersson K; Dejmek J; Nielsen CK; Villoutreix BO; Andersson T
J Biol Chem; 2006 Feb; 281(5):2740-9. PubMed ID: 16330545
[TBL] [Abstract][Full Text] [Related]
40. Suppressing Wnt signaling by the hedgehog pathway through sFRP-1.
He J; Sheng T; Stelter AA; Li C; Zhang X; Sinha M; Luxon BA; Xie J
J Biol Chem; 2006 Nov; 281(47):35598-602. PubMed ID: 17035233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
